Independent transcriptional reprogramming and apoptosis induction by cisplatin

Lorenzo Galluzzi, Ilio Vitale, Laura Senovilla, Tobias Eisenberg, Didac Carmona-Gutierrez, Erika Vacchelli, Thomas Robert, Hugues Ripoche, Nora Jägemann, Caroline Paccard, Nicolas Servant, Philippe Hupé, Vladimir Lazar, Philippe Dessen, Emmanuel Barillot, Hans Zischka, Frank Madeo, Guido Kroemer

Research output: Contribution to journalArticlepeer-review


Neither the molecular mechanisms whereby cancer cells intrinsically are or become resistant to the DNA-damaging agent cisplatin nor the signaling pathways that account for cisplatin cytotoxicity have thus far been characterized in detail. In an attempt to gain further insights into the molecular cascades elicited by cisplatin (leading to resistance or underpinning its antineoplastic properties), we comparatively investigated the ability of cisplatin, C2-ceramide and cadmium dichloride, alone or in the presence of an array of mitochondrion-protective agents, to trigger the permeabilization of purified mitochondria. In addition, we compared the transcriptional response triggered by cisplatin, C2-ceramide and cadmium dichloride in non-small cell lung carcinoma A549 cells. Finally, we assessed the capacity of cisplatin, C2-ceramide and cadmium dichloride to reduce the clonogenic potential of a battery of yeast strains lacking proteins involved in the regulation of cell death, DNA damage signaling and stress management. This multipronged experimental approach revealed that cisplatin elicits signaling pathways that are for the most part "private," i.e., that manifest limited overlap with the molecular cascades ignited by other inducers of mitochondrial apoptosis, and triggers apoptosis mainly in a transcription-independent fashion. Indeed, bona fide cisplatin-response modifiers that we have recently identified by a functional genome-wide siRNA screen are either not transcriptionally regulated during cisplatin-induced cell death or their transcriptional modulation reflects the activation of an adaptive response promoting cisplatin resistance.

Original languageEnglish
Pages (from-to)3472-3480
Number of pages9
JournalCell Cycle
Issue number18
Publication statusPublished - Sep 15 2012


  • Autophagy
  • Bongkrekic acid
  • Cyclosporine A
  • Glutathione
  • Large-amplitude swelling
  • N-acetyl-cysteine

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Developmental Biology


Dive into the research topics of 'Independent transcriptional reprogramming and apoptosis induction by cisplatin'. Together they form a unique fingerprint.

Cite this